A Phase 3 Studyof Pembrolizumab in Combination with Carboplatin/Taxane (Paclitaxel or Nab-paclitaxel) Followed by Pembrolizumab with or without Maintenance Olaparib in the First-line Treatment of Metastatic Squamous Non-small Cell Lung Cancer (NSCLC)
Yazıcı O. (Executive), Özdemir N., Kurt İnci B., Gürler F.
Other International Funding Programs, 2019 - 2021
- Project Type: Other International Funding Programs
- Begin Date: January 2019
- End Date: March 2021